MICHAEL D. WALKER
Princeton University · 287 works · 23,179 citations · h-index 59
Top works
- Endarterectomy for Asymptomatic Carotid Artery Stenosis
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery
- Cell-specific expression controlled by the 5′-flanking region of insulin and chymotrypsin genes
- Cell-Specific Expression of the Rat Insulin Gene: Evidence for Role of Two Distinct 5′ Flanking Elements
- Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study
- An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
- Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.
- Clinical Trials in Head Injury
- Neurotoxicity of Commonly Used Antineoplastic Agents
- Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
- Recommendations for Comprehensive Stroke Centers
- Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation
- High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury
- Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
- Chemotherapy for malignant gliomas
- Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
- Initial clinical trials with methyl-ccnu 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (meccnu)
- A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer.
- Neurotoxicity of Commonly Used Antineoplastic Agents